Timedora
Free Practice Quiz Question List

4 Chronic Kidney Disease Practice Questions Online Quiz Questions

Use this free practice quiz with 20 questions to review 4 Chronic Kidney Disease, test your knowledge, and prepare for your next test or exam.

20 questions
01
Written response
1 point

Which measure estimates kidney filtering function and is used to assess and monitor chronic kidney disease? Enter the abbreviation.

02
Fill in the blank
1 point

For an abnormality such as reduced eGFR or a marker of kidney damage to meet the chronicity criterion for CKD, it must persist for at least .

03
True or false
1 point

True or false: Everyone with CKD should severely restrict fluids and avoid all foods containing potassium.

  1. A

    True

  2. B

    False

04
True or false
1 point

True or false: A single eGFR and UACR result can determine exactly how an individual person's CKD will progress.

  1. A

    True

  2. B

    False

05
Choose one
1 point

How should a care team determine how often to monitor a person's CKD?

  1. A

    Use the same fixed schedule for everyone with CKD.

  2. B

    Tailor the frequency to the person's risk and clinical situation.

  3. C

    Monitor only when symptoms develop.

  4. D

    Stop monitoring once a treatment plan is in place.

06
Choose all
1 point

Which actions can help reduce the risk of further kidney damage? Select all that apply.

  1. A

    Follow the treatment plan for high blood pressure or diabetes.

  2. B

    Review medicines and supplements with a clinician.

  3. C

    Stop prescribed medicines whenever feeling well.

  4. D

    Avoid unnecessary use of NSAIDs.

07
Choose one
1 point

Which statement best describes the role of an SGLT2 inhibitor in CKD?

  1. A

    It is used only to lower blood glucose in people with diabetes.

  2. B

    It may protect kidney and cardiovascular health in eligible people with CKD, including some without diabetes.

  3. C

    It should always be stopped if eGFR falls below 60 mL/min/1.73 m260\,\mathrm{mL/min/1.73\,m^2}.

  4. D

    It removes the need for routine CKD monitoring.

08
Fill in the blank
1 point

For one CKD group described in the guidance, adults have eGFR at least mL/min/1.73 m2\mathrm{mL/min/1.73\,m^2} and UACR at least mg/g\mathrm{mg/g} when an SGLT2 inhibitor is recommended.

09
Choose one
1 point

A patient has an eGFR of 42 mL/min/1.73 m242\,\mathrm{mL/min/1.73\,m^2} and a UACR of 420 mg/g420\,\mathrm{mg/g}. Which interpretation is best?

  1. A

    The UACR is normal because it is measured in mg/g\mathrm{mg/g}.

  2. B

    The reduced eGFR and severely increased albuminuria are both important risk markers.

  3. C

    The results prove that kidney failure will occur soon.

  4. D

    The eGFR alone determines the person's risk and follow-up needs.

10
Choose all
1 point

Which test-result trends may suggest CKD is progressing? Select all that apply.

  1. A

    A sustained decline in eGFR.

  2. B

    One isolated eGFR change during a temporary illness.

  3. C

    A persistent rise in UACR.

  4. D

    One elevated UACR result with no follow-up measurement.

11
Written response
1 point

Besides dialysis options and transplant evaluation, what supportive care option can a person with advanced CKD discuss with the kidney-care team?

12
Choose one
1 point

A patient with albuminuric CKD starts an ACE inhibitor. Which follow-up plan is most appropriate?

  1. A

    Check blood pressure, serum creatinine, and potassium within about 2–4 weeks, as clinically appropriate.

  2. B

    Stop the medicine if creatinine rises by any amount.

  3. C

    Do not recheck laboratory tests unless symptoms develop.

  4. D

    Check urine culture after one year.

13
Choose one
1 point

A person with advanced CKD asks whether to wait until feeling very ill before discussing dialysis or transplant. What is the most helpful response?

  1. A

    Wait until the person feels very ill before discussing any options.

  2. B

    Discuss options early with the kidney-care team so there is time to learn and prepare.

  3. C

    Use one eGFR value to set a universal date to start dialysis.

  4. D

    Discuss transplant only after dialysis has begun.

14
Open ended
1 point

A person with CKD starts a kidney-protective medicine. At follow-up, eGFR has fallen by 12%12\%, but the person feels well. What should the care team consider before changing treatment?

15
Choose one
1 point

Which pair of tests is routinely used to assess CKD and monitor its course?

  1. A

    Serum sodium and urine culture.

  2. B

    Blood urea nitrogen and urine ketones.

  3. C

    eGFR and urine albumin-to-creatinine ratio (UACR).

  4. D

    Serum calcium and urine specific gravity.

16
True or false
1 point

True or false: An SGLT2 inhibitor may protect kidney and cardiovascular health in some eligible people with CKD who do not have diabetes.

  1. A

    True

  2. B

    False

17
Choose one
1 point

Which finding best supports chronic kidney disease rather than a temporary abnormality?

  1. A

    One eGFR result below 60

  2. B

    An eGFR below 60 or another marker of kidney damage that persists for at least 3 months

  3. C

    One elevated urine albumin result during a urinary infection

  4. D

    A single creatinine increase after dehydration

18
Written response
1 point

Which class of over-the-counter pain medicines should a person with CKD ask their care team about before using?

19
Choose one
1 point

A patient with albuminuric CKD starts an ACE inhibitor. Which monitoring plan is most appropriate?

  1. A

    Check blood pressure, serum creatinine, and potassium within about 2–4 weeks, as clinically appropriate.

  2. B

    Stop the medicine if creatinine rises by any amount.

  3. C

    Wait to recheck laboratory tests unless symptoms develop.

  4. D

    Check a urine culture after one year.

20
Written response
1 point

After starting a hemodynamically active treatment, an eGFR decline greater than what percentage warrants evaluation?